Adjuvant Treatment of Triple-Negative Metaplastic Breast Cancer With Weekly Paclitaxel and Platinum Chemotherapy: Retrospective Case Review From a Single Institution

被引:6
|
作者
Harper, Natalie W. [1 ]
Hodges, Kurt B. [2 ]
Stewart, Rachel L. [2 ,5 ]
Wu, Jianrong [3 ,5 ]
Huang, Bin [3 ,5 ]
O'Connor, Kathleen L. [4 ,5 ]
Romond, Edward H. [1 ,5 ]
机构
[1] Univ Kentucky, Dept Internal Med, Div Med Oncol, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY 40536 USA
[3] Univ Kentucky, Biostat & Bioinformat Shared Resource Facil, Markey Canc Ctr, Lexington, KY 40536 USA
[4] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA
[5] Univ Kentucky, Markey Canc Ctr, 203 Combs Bldg, Lexington, KY 40536 USA
基金
美国国家卫生研究院;
关键词
Carboplatin; Taxane; TUMOR-INITIATING CELLS; MESENCHYMAL TRANSITION; SARCOMATOID CARCINOMA; CARBOPLATIN; OUTCOMES; MARKERS; TRIAL;
D O I
10.1016/j.clbc.2019.05.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:E495 / E500
页数:6
相关论文
共 50 条
  • [21] Demography and treatment outcomes of triple-negative breast cancer: A single institution study
    James, S. E.
    Vosand, P.
    Biswas, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [22] Triple-negative metastatic/recurrent breast cancer: Treatment with paclitaxel/carboplatin combination chemotherapy
    Chia, J. W.
    Ang, P.
    See, H.
    Wong, Z.
    Soh, L.
    Yap, Y.
    Wong, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] ADJUVANT RADIOTHERAPY FOR METAPLASTIC BREAST CANCER: RETROSPECTIVE ANALYSIS OF A SPANISH SINGLE INSTITUTION
    Quispe, K.
    Moreno, F.
    Catala, T.
    Petit, A.
    Villena, N.
    Arancha, E.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S229 - S229
  • [24] Triple-negative metaplastic breast cancer: treatment and prognosis by type of surgery
    Hu, Jin
    Dong, Fang
    Zhang, Yanting
    Shen, Jian
    Ming, Jie
    Huang, Tao
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (10): : 11689 - 11696
  • [25] Histologic Pattern and Outcomes in High-Grade Metaplastic Breast Cancer Compared to Triple-Negative Ductal Breast Cancer Counterparts: A Single Institution Retrospective Study
    Matusz-Fisher, Ashley
    Chen, Annabel
    Donahue, Erin
    Schepel, Courtney
    Wallander, Michelle
    Livasy, Chad
    White, Richard
    Tan, Antoinette
    Hadzikadic-Gusic, Lejla
    CANCER RESEARCH, 2024, 84 (09)
  • [26] Adjuvant chemotherapy in small node-negative triple-negative breast cancer
    Steenbruggen, Tessa G.
    van Werkhoven, Erik
    van Ramshorst, Mette S.
    van Ramshorst, Mette S.
    Dezentje, Vincent O.
    Kok, Marleen
    Linn, Sabine C.
    Siesling, Sabine
    Sonke, Gabe S.
    EUROPEAN JOURNAL OF CANCER, 2020, 135 : 66 - 74
  • [27] A Single Institution Experience of Incorporation of Cisplatin into Adjuvant Chemotherapy for Patients With Triple-Negative Breast Cancer of Unknown BRCA Mutation Status
    Su, Ying-Wen
    Hung, Chia-Yen
    Lam, Hung-Bun
    Chang, Yuan-Ching
    Yang, Po-Sheng
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2018, 12
  • [28] The effect of delayed adjuvant chemotherapy on relapse of triple-negative breast cancer
    Li, Shuang
    Ma, Ding
    Shi, Hao-Hong
    Yu, Ke-Da
    Zhang, Qiang
    JOURNAL OF THORACIC DISEASE, 2018, 10 (05) : 2837 - 2841
  • [29] Efficacy of Sequential Capecitabine on Adjuvant Chemotherapy of Triple-Negative Breast Cancer
    Xi, Xun
    Huang, Xingwei
    Yuan, Huozhong
    Ni, Jun
    Yang, Fulan
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [30] The Role of Adjuvant Chemotherapy for Elderly Women with Triple-Negative Breast Cancer
    Lan, Tian
    Guo, Qiusheng
    Lu, Yunyan
    Gu, Junwei
    Shao, Xiying
    Xu, Haibin
    Hu, Zujian
    CANCER RESEARCH, 2023, 83 (05)